Compare BDRX & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDRX | IBG |
|---|---|---|
| Founded | 2000 | 2018 |
| Country | United Kingdom | Australia |
| Employees | N/A | 9 |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0M | 2.0M |
| IPO Year | 2015 | N/A |
| Metric | BDRX | IBG |
|---|---|---|
| Price | $3.04 | $1.04 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 84.2K | ★ 258.0K |
| Earning Date | 09-12-2025 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.60 | $0.30 |
| 52 Week High | $11.88 | $6.50 |
| Indicator | BDRX | IBG |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 37.62 |
| Support Level | $2.86 | $0.97 |
| Resistance Level | $4.39 | $1.31 |
| Average True Range (ATR) | 0.27 | 0.10 |
| MACD | -0.14 | 0.05 |
| Stochastic Oscillator | 8.45 | 9.07 |
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.